LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $825,656 | +12.5% | 11,452 | +14.8% | 0.01% | 0.0% |
| Q1 2023 | $733,615 | +92.0% | 9,973 | +148.7% | 0.01% | +25.0% |
| Q3 2020 | $382,000 | -13.8% | 4,010 | +1.3% | 0.01% | -20.0% |
| Q2 2020 | $443,000 | -54.6% | 3,958 | -44.9% | 0.01% | -58.3% |
| Q4 2018 | $975,000 | -56.7% | 7,188 | -12.4% | 0.02% | -48.9% |
| Q3 2018 | $2,251,000 | +21.5% | 8,202 | -8.3% | 0.05% | +17.5% |
| Q2 2018 | $1,852,000 | +63.3% | 8,941 | +8.0% | 0.04% | +60.0% |
| Q4 2017 | $1,134,000 | -4.9% | 8,282 | -5.5% | 0.02% | -10.7% |
| Q3 2017 | $1,193,000 | +353.6% | 8,760 | +256.1% | 0.03% | +250.0% |
| Q1 2016 | $263,000 | -11.1% | 2,460 | -28.8% | 0.01% | -20.0% |
| Q3 2015 | $296,000 | – | 3,453 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |